Hyperleukocytosis

Acute Myeloid Leukemia

With the development of new scientific techniques, international collaborations and clinical trials, treatment options for AML are likely to increase in future years. We hope that this will translate into improved prognosis and quality of life for patients with this devastating disease - Connor Sweeney & Catherine Garnett

image by: The Leukemia & Lymphoma Society

HWN Recommends

Scientists uncover 11 types of acute myeloid leukaemia

The blood cancer known as acute myeloid leukaemia (AML) is not one disease but at least 11 different types, scientists have concluded by studying the genes that cause the condition.

Scientists say the discovery could aid diagnosis and lead to new treatments geared towards tackling the different types of the disease.

“What it will mean is that we can give much more accurate information to the patient about what is likely to happen to them with the conventional treatments,” said Peter Campbell, co-author of the study from the Wellcome Trust Sanger Institute. “In the long term we hope that this will act as a framework for developing and testing new targeted drugs,” he added...

While…

read full article

Resources

The Awful Coincidence of 2 Friends Who Got the Same Cancer

“I think we were meant to walk through this together.”

Acute Myeloid Leukaemia

Acute myeloid leukaemia (AML) is the most common form of acute leukaemia in adults, although it is considered a rare disease. The disease often affects the older person and is uncommon before the age of 45. Incidence is expected to rise with an ageing population and place greater demands on healthcare systems. Our report, which looks at the policy response in five European countries as well as the patient experience, is available at the Economist Intelligence Unit’s World Cancer Initiative.

Acute myeloid leukaemia: researchers zero in on treatment options for aggressive blood cancer

AML is the commonest aggressive adult human blood cancer. Despite advances in our understanding of the disease, we need to do more research to increase the number of patients who are cured.

Diagnosis and management of acute myeloid leukemia in adults

In 2003, an international working group last reported on recommendations for diagnosis, response assessment, and treatment outcomes in acute myeloid leukemia (AML). Since that time, considerable progress has been made in elucidating the molecular pathogenesis of the disease that has resulted in the identification of new diagnostic and prognostic markers. Furthermore, therapies are now being developed that target disease-associated molecular defects.

Jennifer’s Story about Acute Myelogenous Leukemia (AML)

Transplanted cord blood is an alternative that broadens access to curative transplants especially for minority patients and it has good outcomes - Juliet Barker

New discoveries reveal how acute myeloid leukemia walks line between growth and cell death

AML is a cancer of the blood cells that can occur when immature white blood cells, cells that normally fight infection, acquire certain genetic mutations that cause them to multiply rapidly and build up the bone marrow and blood. It is the most common acute leukemia in adults and usually gets worse quickly if it is not treated.

Running for My Life: Fighting Cancer One Step at a Time

This is my story of running into a diagnosis of Acute Myeloid Leukemia, or AML, in 2003 after feeling unusually winded while running a 10K race. It is a story of falling down and getting up and falling down and getting up many times over, with two relapses, life-threatening complications, life-long side effects... and a determination to keep moving.

Scientists uncover 11 types of acute myeloid leukaemia

Discovery that there are more categories of disease than previously thought could aid diagnosis and lead to new treatments

Aplastic Anemia and MDS International Foundation

When people have AML, blasts make copies of themselves quickly. This slows the production of red blood cells and platelets, causing tiredness from anemia and a risk of bleeding from a low platelet count. There is also an increased risk of infection, since infection-fighting white blood cells are not maturing and cannot fight off infection. AML is also known as acute myelogenous leukemia, acute myeloblastic leukemia and acute nonlymphocytic leukemia.